PRE

MKT CAP:$257M

Prenetics Global Limited

Market Cap

$257M

Healthcare·Medical - Diagnostics & Research·🇭🇰 Hong Kong·NASDAQ

Healthcare·Medical·🇭🇰·NASDAQ

Stock Price

$17.89+$2.11 (+13.37%)

Apr 21, 2026

Company Details

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring sy...

CEO

Sheng Wu Yeung

IPO Date

Jul 16, 2021

Website

www.prenetics.com

Key Metrics TTM

Revenue

$69M

+176.0% YoY

Net Income

-$47M

EPS (Diluted)

-$3.56

Free Cash Flow

$0

Revenue / Share

$4.97

Gross Margin

47.2%

Operating Margin

-62.9%

Net Margin

-67.4%

FCF Margin

0.0%

P/S

3.7x

P/E

—

Earnings Reports

Q3 2025

Nov 10, 2025

$24M+202.8%EPS -$0.53

Q2 2025

Sep 12, 2025

$18M+197.6%EPS -$0.94

Q1 2025

Aug 22, 2025

$17M+170.0%EPS -$0.80

Q4 2024

Apr 30, 2025

$10MEPS -$1.29

Q3 2024

Sep 30, 2024

$8M+59.4%EPS -$0.84

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 20	$4M	$2M	-$4M
Q2 20	$8M	$2M	-$1M
Q3 20	$26M	$14M	$7M
Q4 20	$27M	$9M	-$3M
Q1 21	$57M	$22M	$11M
Q2 21	$79M	$35M	$15M
Q3 21	$75M	$26M	-$5M
Q4 21	$65M	$24M	-$31M
Q3 23	$5M	$2M	-$13M
Q1 24	$6M	$4M	-$9M
Q2 24	$6M	$4M	-$11M
Q3 24	$8M	$4M	-$12M
Q4 24	$10M	$4M	-$17M
Q1 25	$17M	$7M	-$11M
Q2 25	$18M	$7M	-$10M
Q3 25	$24M	$14M	-$6M

Valuation

Quarter	P/S	P/E
Q1 20	—	—
Q2 20	—	—
Q3 20	—	—
Q4 20	12.9x	—
Q1 21	7.1x	1410.7x
Q2 21	4.4x	—
Q3 21	3.6x	—
Q4 21	3.1x	—
Q3 23	0.4x	—
Q1 24	0.3x	—
Q2 24	0.9x	—
Q3 24	2.0x	—
Q4 24	2.4x	—
Q1 25	1.2x	—
Q2 25	2.1x	—
Q3 25	2.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 20	-$2M	-$2M
Q2 20	$4M	$4M
Q3 20	-$3M	-$4M
Q4 20	-$2M	-$4M
Q1 21	-$7M	-$9M
Q2 21	-$1M	-$1M
Q3 21	-$72.0K	-$72.0K
Q4 21	$15M	$6M
Q3 23	$0	$0
Q1 24	$0	$0
Q2 24	$0	$0
Q3 24	$0	$0
Q4 24	$0	$0
Q1 25	$0	$0
Q2 25	$0	$0
Q3 25	$0	$0

Capital Expenditures

Quarter	CapEx
Q1 20	$8.5K
Q2 20	$292.2K
Q3 20	$641.0K
Q4 20	$2M
Q1 21	$2M
Q2 21	$1
Q3 21	$1
Q4 21	$9M
Q3 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 21	+1314.8%	+492.0%
Q2 21	+897.8%	+590.6%
Q3 21	+188.0%	+326.6%
Q4 21	+137.3%	+215.2%
Q3 23	-91.5%	-61.6%
Q1 24	-91.9%	-75.7%
Q2 24	-92.0%	-79.3%
Q3 24	-88.0%	-79.5%
Q4 24	+115.0%	+51.8%
Q1 25	+170.0%	+79.4%
Q2 25	+197.6%	+67.6%
Q3 25	+202.8%	+51.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 20	$512.5K	12.6%
Q2 20	$330.2K	4.2%
Q3 20	$2M	6.5%
Q4 20	-$897.8K	-3.3%
Q1 21	$93.5K	0.2%
Q2 21	$0	0.0%
Q3 21	$0	0.0%
Q4 21	$0	0.0%
Q3 23	$4M	90.1%
Q1 24	$2M	30.2%
Q2 24	$2M	25.4%
Q3 24	$1M	17.9%
Q4 24	$3M	28.5%
Q1 25	$1M	6.4%
Q2 25	$2M	10.7%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 20	$509.3K	$3M	$2M
Q2 20	$369.0K	$2M	$1M
Q3 20	$792.5K	$4M	$1M
Q4 20	$1M	$7M	$2M
Q1 21	$1M	$8M	$2M
Q2 21	$2M	$14M	$4M
Q3 21	$2M	$23M	$5M
Q4 21	$5M	$39M	$10M
Q3 23	$4M	$11M	$2M
Q1 24	$3M	$9M	$2M
Q2 24	$3M	$10M	$2M
Q3 24	$3M	$11M	$2M
Q4 24	$3M	$17M	$2M
Q1 25	$2M	$11M	$5M
Q2 25	$1M	$10M	$5M
Q3 25	$1M	$10M	$10M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$34M	$10M	$44M
Q2 22	$134M	$27M	$161M
Q3 22	$145M	$25M	$170M
Q4 22	$147M	$37M	$184M
Q1 23	$166M	$37M	$204M
Q2 23	$177M	$14M	$191M
Q3 23	$71M	$14M	$85M
Q4 23	$46M	$27M	$73M
Q1 24	$55M	$11M	$66M
Q2 24	$41M	$11M	$52M
Q3 24	$32M	$11M	$43M
Q4 24	$52M	$11M	$63M
Q1 25	$48M	$11M	$59M
Q2 25	$17M	$10M	$28M
Q3 25	$13M	$10M	$24M
Q4 25	$32M	$29M	$61M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 20	1M	—	—
Q2 20	1M	0.0%	—
Q3 20	9M	+755.7%	—
Q4 20	1M	-87.3%	—
Q1 21	4M	+213.0%	+240.7%
Q2 21	3M	-30.8%	+135.8%
Q3 21	4M	+44.5%	-60.2%
Q4 21	4M	-2.1%	+206.5%
Q3 23	12M	+217.4%	+210.9%
Q1 24	12M	+4.0%	+367.3%
Q2 24	12M	+0.1%	+223.6%
Q3 24	13M	+4.1%	+243.9%
Q4 24	13M	-0.1%	+8.2%
Q1 25	13M	+2.3%	+6.4%
Q2 25	13M	+1.9%	+8.4%
Q3 25	14M	+4.9%	+9.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 20	—	—
Q2 20	—	—
Q3 20	—	—
Q4 20	—	—
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q3 23	$12.2K	400
Q1 24	$19.8K	324
Q2 24	$18.3K	324
Q3 24	$24.0K	324
Q4 24	$36.8K	285
Q1 25	$60.7K	285
Q2 25	$62.0K	285
Q3 25	$82.6K	285

Revenue / Employee